---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-020555"
form_type: "8-K"
ticker: "MYO"
cik: "0001369290"
company_name: "MYOMO, INC."
filed_at: "2023-05-10T23:59:59+00:00"
generated_at: "2026-06-15T06:05:25.536114+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Myomo Q1 product rev up 20% to $3.4M; record 438 pipeline patients added

## Summary
- Product revenue $3.4M, +20% YoY; total revenue $3.4M (-11% due to prior-year license fee).
- Record 438 new pipeline patients from previous payers (+54% YoY); total pipeline 855 (+28%).
- Cost per pipeline add $1,579 (down 53% YoY, 50% sequentially).
- Net loss $2.6M ($0.11 per share) vs $2.8M ($0.43) in Q1 2022.
- Guides 20-30% product revenue growth for 2023; cash $11M after April license fee.

## SEC filing metadata
- accession: 0000950170-23-020555
- form_type: 8-K
- ticker: MYO
- cik: 0001369290
- company_name: MYOMO, INC.
- filed_at: 2023-05-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1369290/000095017023020555/0000950170-23-020555-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1369290/000095017023020555/myo-20230510.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-020555
- JSON: https://secwatch.observer/filing/0000950170-23-020555.json
- Plain text: https://secwatch.observer/filing/0000950170-23-020555.txt

## Key facts
- Earnings Releases
  MYOMO, INC. reported financial results for the three months ended March 31, 2023.
  - Period: the three months ended March 31, 2023
  - Result: reported results
  source text: On May 10, 2023, Myomo, Inc, (the "Company") announced its financial results for the first quarter ended March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1369290/000095017023020555/0000950170-23-020555-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.